Overview
Paul Viscuse is an Oncologist in Charlottesville, Virginia. Dr. Viscuse has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Urothelial Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Renal Cell Carcinoma (RCC). Dr. Viscuse is currently accepting new patients.
His clinical research consists of co-authoring 24 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1215 Lee St, Charlottesville, VA 22908
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Virginia Physicians Group
Ryan Gentzler is an Oncologist in Charlottesville, Virginia. Dr. Gentzler is rated as an Elite provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Gentzler is currently accepting new patients.
University Of Virginia Physicians Group
Richard Hall is an Oncologist and a Hematologist in Charlottesville, Virginia. Dr. Hall is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Gamma Knife Radiosurgery, and Endoscopy. Dr. Hall is currently accepting new patients.
Virginia Cancer Institute Incorporated
Will Voelzke is a Hematologist Oncology specialist and a Hematologist in North Chesterfield, Virginia. Dr. Voelzke is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Dehydration, Anal Cancer, Pleuropulmonary Blastoma, and Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Muscle Invasive Bladder CancerDr. Viscuse isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Viscuse isAdvanced. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Viscuse isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerDr. Viscuse isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Adrenal CancerDr. Viscuse isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Viscuse isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Viscuse isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Viscuse isExperienced. Learn about Bladder Cancer.
- ChoriocarcinomaDr. Viscuse isExperienced. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Viscuse isExperienced. Learn about Chromophobe Renal Cell Carcinoma.